ClinicalTrials.Veeva

Menu

Picture of Incidental Calcium To Understand Risk Estimate (PICTURE) Trial

Stanford University logo

Stanford University

Status

Active, not recruiting

Conditions

Coronary Artery Calcification

Treatments

Other: Notification

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a prospective randomized controlled trial assessing the impact of notifying patients and their clinicians of an incidental finding of coronary artery calcification (CAC) indicating increased cardiovascular risk. Patients will be identified through completed radiology orders for non-gated, non-contrast chest CT in the appropriate clinical context and then will have an EHR screen for inclusion criteria. The presence of CAC will be confirmed by a radiologist. Eligible patients will be randomized to CAC notification or usual care using a 1:1 stratified block randomization method based on baseline ASCVD.

Enrollment

202 patients

Sex

All

Ages

18 to 84 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 and above and <85

  • Non-gated chest CT with CAC

  • An encounter after July 1, 2021 with a Stanford-affiliated clinician from one of the following clinics:

    • Stanford Internal Medicine (includes University affiliated clinics)
    • Stanford Family Medicine (includes University affiliated clinics)
    • Non-EP cardiologist

Exclusion criteria

  • Advanced or poor-prognostic cancer
  • No active primary care or cardiology care at Stanford Health Care
  • Primary language other than English, Spanish, Vietnamese, Cantonese, or Mandarin
  • Baseline statin or non-statin lipid lowering therapy
  • Allergy to statin medication or identification of statin-associated muscle symptom

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

202 participants in 2 patient groups

Notification
Experimental group
Description:
The notification arm will have its CT scans interpreted and reported according to standard clinical practice. A standardized notification message using the EHR will be sent to the patient's Stanford affiliated non-EP cardiologist, if present, or the primary care clinician if there is no non-EP cardiologist. After a two week delay from notifying the patient's non-EP cardiologist or PCP, a standardized notification message will be sent to the patient. The message will include an image of the CAC from the chest CT. All communications will be signed by the Principal Investigator. Any treatment decisions will be made by the patient and their clinician.
Treatment:
Other: Notification
Usual Care
No Intervention group
Description:
The usual care arm will have its CT scans interpreted and reported according to standard clinical practice. This may mention the presence of CAC in the official radiology imaging report, per usual practice. The usual care arm will not receive any notification beyond this standard of care. We intend to notify patients in the usual care arm when study ends, if we determine that notification is effective at increasing statin rates.

Trial contacts and locations

1

Loading...

Central trial contact

Shiqin Xu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems